Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

NCT00000923 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

110

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Lamivudine
DRUG: Stavudine
DRUG: Zidovudine
DRUG: Didanosine
DRUG: Aldesleukin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)